131 related articles for article (PubMed ID: 618598)
1. Plasma vasopressin concentrations and effects of vasopressin antiserum on blood pressure in rats with malignant two-kidney Goldblatt hypertension.
Möhring J; Möhring B; Petri M; Haack D
Circ Res; 1978 Jan; 42(1):17-22. PubMed ID: 618598
[TBL] [Abstract][Full Text] [Related]
2. Vasopressor role of ADH in the pathogenesis of malignant DOC hypertension.
Möhring J; Möhring B; Petri M; Haack D
Am J Physiol; 1977 Mar; 232(3):F260-9. PubMed ID: 842673
[TBL] [Abstract][Full Text] [Related]
3. Vasopressin and malignant deoxycorticosterone hypertension in rats.
Möhring J; Möhring B; Petri M; Haack D
Clin Sci Mol Med Suppl; 1976 Dec; 3():45s-48s. PubMed ID: 1071663
[TBL] [Abstract][Full Text] [Related]
4. Neurohypophyseal vasopressor principle: vasopressor hormone as well as antidiuretic hormone?
Möhring J
Klin Wochenschr; 1978; 56 Suppl 1():71-9. PubMed ID: 732254
[TBL] [Abstract][Full Text] [Related]
5. Effects of saline drinking on malignant course of renal hypertension in rats.
Möhring J; Petri M; Szokol M; Haack D; Möhring B
Am J Physiol; 1976 Mar; 230(3):849-57. PubMed ID: 1266989
[TBL] [Abstract][Full Text] [Related]
6. Pathogenesis of malignant hypertension: experimental evidence from the renal hypertensive rat.
Möhring J
Clin Nephrol; 1975 Nov; 4(5):167-74. PubMed ID: 1192618
[TBL] [Abstract][Full Text] [Related]
7. Is vasopressin involved in the pathogenesis of malignant desoxycorticosterone hypertension in rats?
Möhring J; Möhring B; Petri M; Haack D
Lancet; 1976 Jan; 1(7952):170-3. PubMed ID: 54684
[TBL] [Abstract][Full Text] [Related]
8. Relative contribution of vasopressin and angiotensin II to the altered renal microcirculatory dynamics in two-kidney Goldblatt hypertension.
Ichikawa I; Ferrone RA; Duchin KL; Manning M; Dzau VJ; Brenner BM
Circ Res; 1983 Nov; 53(5):592-602. PubMed ID: 6194914
[TBL] [Abstract][Full Text] [Related]
9. Studies on the role of vasopressin in blood pressure control of spontaneously hypertensive rats with established hypertension (SHR, stroke-prone strain).
Möhring J; Kintz J; Schoun J
J Cardiovasc Pharmacol; 1979; 1(6):593-608. PubMed ID: 94626
[TBL] [Abstract][Full Text] [Related]
10. Evidence against a role of vasopressin in the maintenance of high blood pressure in mineralocorticoid and renovascular hypertension.
Rabito SF; Carretero OA; Scicli AG
Hypertension; 1981; 3(1):34-8. PubMed ID: 7009426
[TBL] [Abstract][Full Text] [Related]
11. Contribution of vasopressin and the sympathetic nervous system in the early phase of high sodium one-kidney renal hypertension.
Hinojosa C; Haywood JR
Hypertension; 1984; 6(6 Pt 1):848-54. PubMed ID: 6240442
[TBL] [Abstract][Full Text] [Related]
12. Effect of vasopressin blockade on blood pressure in conscious rats with malignant two-kidney Goldblatt hypertension.
Filep J; Frölich JC; Fejes-Tóth G
Clin Exp Hypertens A; 1985; 7(7):1007-14. PubMed ID: 3840065
[TBL] [Abstract][Full Text] [Related]
13. Plasma vasopressin concentration in high sodium renal hypertension.
Hinojosa C; Shade RE; Haywood JR
J Hypertens; 1986 Oct; 4(5):529-34. PubMed ID: 3794328
[TBL] [Abstract][Full Text] [Related]
14. Development of high sodium renal hypertension during chronic blockade of the vascular effects of vasopressin.
Hinojosa C; Haywood JR
J Pharmacol Exp Ther; 1986 Aug; 238(2):492-6. PubMed ID: 2874211
[TBL] [Abstract][Full Text] [Related]
15. Selective renal medullary damage and hypertension in the rat: the role of vasopressin.
Russell GI; Godfrey NP; Forsling ML; Bing RF; Thurston H; Swales JD
Clin Sci (Lond); 1986 Aug; 71(2):167-71. PubMed ID: 3522050
[TBL] [Abstract][Full Text] [Related]
16. Plasma renin and sodium balance during development of moderate and severe renal hypertension in rats.
Leenen FH; de Jong W
Circ Res; 1975 Jun; 36(6 Suppl 1):179-86. PubMed ID: 1132077
[TBL] [Abstract][Full Text] [Related]
17. Plasma vasopressin in blood pressure homeostasis and in experimental renal hypertension.
Pullan PT; Johnston CI; Anderson WP; Korner PI
Am J Physiol; 1980 Jul; 239(1):H81-7. PubMed ID: 7396022
[TBL] [Abstract][Full Text] [Related]
18. Vascular, renal, and endocrine responses to low-dose atrial natriuretic peptide in the fluid-balanced New Zealand genetically hypertensive rats with and without endogenous arginine vasopressin.
Abu-Amarah I; Balment RJ
Can J Physiol Pharmacol; 1999 Feb; 77(2):102-10. PubMed ID: 10535700
[TBL] [Abstract][Full Text] [Related]
19. [Behavior of the renin-angiotensin-aldosterone system and vasopressin secretion in patients with renovascular hypertension or small kidney].
Wieçek A; Kokot F
Z Gesamte Inn Med; 1985 Mar; 40(6):172-6. PubMed ID: 3890386
[TBL] [Abstract][Full Text] [Related]
20. Malignant hypertension in Brattleboro (vasopressin-deficient) rats.
Woods RL; Abrahams JM; Kincaid-Smith P; Johnston CI
J Hypertens; 1983 Jun; 1(1):37-43. PubMed ID: 6397512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
